D. ÜSKÜDAR CANSU Et Al. , "IS ANTIPHOSPHOLIPID ANTIBODY SYNDROME A RISK FACTOR FOR MORTALITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS," 15th International Antiphospholipid Congress , 2016
ÜSKÜDAR CANSU, D. Et Al. 2016. IS ANTIPHOSPHOLIPID ANTIBODY SYNDROME A RISK FACTOR FOR MORTALITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. 15th International Antiphospholipid Congress .
ÜSKÜDAR CANSU, D., ÜSKÜDAR TEKE, H., & KORKMAZ, C., (2016). IS ANTIPHOSPHOLIPID ANTIBODY SYNDROME A RISK FACTOR FOR MORTALITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS . 15th International Antiphospholipid Congress
ÜSKÜDAR CANSU, DÖNDÜ, HAVA ÜSKÜDAR TEKE, And CENGİZ KORKMAZ. "IS ANTIPHOSPHOLIPID ANTIBODY SYNDROME A RISK FACTOR FOR MORTALITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS," 15th International Antiphospholipid Congress, 2016
ÜSKÜDAR CANSU, DÖNDÜ Ü. Et Al. "IS ANTIPHOSPHOLIPID ANTIBODY SYNDROME A RISK FACTOR FOR MORTALITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS." 15th International Antiphospholipid Congress , 2016
ÜSKÜDAR CANSU, D. ÜSKÜDAR TEKE, H. And KORKMAZ, C. (2016) . "IS ANTIPHOSPHOLIPID ANTIBODY SYNDROME A RISK FACTOR FOR MORTALITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS." 15th International Antiphospholipid Congress .
@conferencepaper{conferencepaper, author={DÖNDÜ ÜSKÜDAR CANSU Et Al. }, title={IS ANTIPHOSPHOLIPID ANTIBODY SYNDROME A RISK FACTOR FOR MORTALITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS}, congress name={15th International Antiphospholipid Congress}, city={}, country={}, year={2016}}